Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.

Martin PT.

Glycobiology. 2003 Aug;13(8):55R-66R. Epub 2003 May 7. Review.

PMID:
12736199
2.

Deficiency of alpha-dystroglycan in muscle-eye-brain disease.

Kano H, Kobayashi K, Herrmann R, Tachikawa M, Manya H, Nishino I, Nonaka I, Straub V, Talim B, Voit T, Topaloglu H, Endo T, Yoshikawa H, Toda T.

Biochem Biophys Res Commun. 2002 Mar 15;291(5):1283-6. Erratum in: Biochem Biophys Res Commun 2002 May 24;293(5):1579.

PMID:
11883957
3.

Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.

Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT.

Neuromuscul Disord. 2003 Jun;13(5):365-75.

PMID:
12798792
4.

Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor.

Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S.

Cell. 1994 Jun 3;77(5):675-86.

PMID:
8205617
5.

Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.

Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP.

J Biol Chem. 1995 Nov 10;270(45):27305-10.

7.

Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins.

Pall EA, Bolton KM, Ervasti JM.

J Biol Chem. 1996 Feb 16;271(7):3817-21.

8.

Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan.

Rosa G, Ceccarini M, Cavaldesi M, Zini M, Petrucci TC.

Biochem Biophys Res Commun. 1996 Jun 14;223(2):272-7.

PMID:
8670271
10.

Dystrophin, utrophin and beta-dystroglycan expression in skeletal muscle from patients with Becker muscular dystrophy.

Kawajiri M, Mitsui T, Kawai H, Kobunai T, Tsuchihashi T, Saito S.

J Neuropathol Exp Neurol. 1996 Aug;55(8):896-903.

PMID:
8759779
11.
13.

Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle.

Cullen MJ, Walsh J, Roberds SL, Campbell KP.

Neuropathol Appl Neurobiol. 1996 Feb;22(1):30-7.

PMID:
8866780
15.

A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.

Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T, Young JB, Campbell KP.

J Mol Cell Cardiol. 1997 Dec;29(12):3175-88.

PMID:
9441825
16.

Costameric distribution of beta-dystroglycan (43 kDa dystrophin-associated glycoprotein) in normal and dystrophin-deficient human skeletal muscle.

Herrmann R, Anderson LV, Voit T.

Biochem Soc Trans. 1996 May;24(2):501-6. Review. No abstract available.

PMID:
8736792
17.

Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.

Huizing M, Rakocevic G, Sparks SE, Mamali I, Shatunov A, Goldfarb L, Krasnewich D, Gahl WA, Dalakas MC.

Mol Genet Metab. 2004 Mar;81(3):196-202.

PMID:
14972325
18.

Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue.

Gesemann M, Brancaccio A, Schumacher B, Ruegg MA.

J Biol Chem. 1998 Jan 2;273(1):600-5.

19.

A role of dystroglycan in schwannoma cell adhesion to laminin.

Matsumura K, Chiba A, Yamada H, Fukuta-Ohi H, Fujita S, Endo T, Kobata A, Anderson LV, Kanazawa I, Campbell KP, Shimizu T.

J Biol Chem. 1997 May 23;272(21):13904-10.

20.

Characterization of dp6troglycan-laminin interaction in peripheral nerve.

Yamada H, Chiba A, Endo T, Kobata A, Anderson LV, Hori H, Fukuta-Ohi H, Kanazawa I, Campbell KP, Shimizu T, Matsumura K.

J Neurochem. 1996 Apr;66(4):1518-24.

PMID:
8627307

Supplemental Content

Support Center